Login to Your Account



Washington Roundup

SEC Files Fraud Charges Against Biotech, Executives

By Mari Serebrov


Thursday, August 4, 2011
WASHINGTON – Immunosyn Corp.'s statements in public filings over the past few years have landed the biotech, its shareholders and senior executives on the wrong side of the SEC.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription